Similar companies
Company | Transaction Value | |
---|---|---|
![]() |
OcugenOCGN |
$620,000 |
![]() |
AmarinAMRN |
$1.7M |
![]() |
Gilead SciencesGILD |
-$381M |
![]() |
Anavex Life SciencesAVXL |
-$14M |
![]() |
Inovio PharmaceuticalsINO |
-$30,000 |
Insider Transactions
Name | Transaction Date | Sold / Bought | Shares | Price | Value |
---|---|---|---|---|---|
WHITE MICHAEL ANTHONY | May 29, 2024 | Sell | 27,649 | $36.2251 | $1M |
WHITE MICHAEL ANTHONY | May 29, 2024 | Sell | 851 | $36.7763 | $31,000 |
Hata Yujiro S | May 16, 2024 | Sell | 30,084 | $41.7333 | $1.3M |
Hata Yujiro S | May 16, 2024 | Sell | 4,349 | $42.366 | $180,000 |
Hata Yujiro S | May 15, 2024 | Sell | 53,592 | $42.5741 | $2.3M |
Hata Yujiro S | May 15, 2024 | Sell | 29,761 | $43.4775 | $1.3M |
Hata Yujiro S | May 15, 2024 | Sell | 503 | $44.1179 | $22,000 |
Hata Yujiro S | May 14, 2024 | Sell | 54,408 | $41.6011 | $2.3M |
Hata Yujiro S | May 14, 2024 | Sell | 2,303 | $41.8357 | $96,000 |
Hata Yujiro S | Feb 9, 2024 | Sell | 23,557 | $45.537 | $1.1M |
Hata Yujiro S | Feb 8, 2024 | Sell | 75,815 | $45.1472 | $3.4M |
Hata Yujiro S | Feb 1, 2024 | Sell | 624 | $45 | $28,000 |
Hata Yujiro S | Feb 1, 2024 | Sell | 4 | $45.01 | $180 |
Ruiz Briseno Andres | Jan 22, 2024 | Sell | 2,000 | $42.0251 | $84,000 |
Hata Yujiro S | Jan 16, 2024 | Sell | 62,739 | $40.1659 | $2.5M |
Hata Yujiro S | Jan 12, 2024 | Sell | 12,261 | $40.0386 | $490,000 |
Ruiz Briseno Andres | Jan 12, 2024 | Sell | 2,000 | $38.0128 | $76,000 |
Throne Jason | Dec 15, 2023 | Sell | 10,000 | $35.0371 | $350,000 |
Hata Yujiro S | Dec 15, 2023 | Sell | 75,000 | $35.0349 | $2.6M |
Ruiz Briseno Andres | Dec 14, 2023 | Sell | 1,672 | $34 | $57,000 |
Ruiz Briseno Andres | Dec 14, 2023 | Sell | 328 | $34.005 | $11,000 |
Throne Jason | Nov 3, 2023 | Sell | 5,163 | $30.091 | $160,000 |
Throne Jason | Sep 12, 2023 | Sell | 500 | $30.01 | $15,000 |
Throne Jason | Sep 5, 2023 | Sell | 1,737 | $30.0287 | $52,000 |
Throne Jason | Sep 1, 2023 | Sell | 2,100 | $30.0298 | $63,000 |
Ruiz Briseno Andres | Sep 1, 2023 | Sell | 2,000 | $30.008 | $60,000 |
Stone Paul A. | Aug 29, 2023 | Sell | 5,000 | $28.8703 | $140,000 |
Stone Paul A. | Aug 21, 2023 | Sell | 978 | $26.4003 | $26,000 |
Stone Paul A. | Aug 18, 2023 | Sell | 3,822 | $26.3789 | $100,000 |
Stone Paul A. | Aug 16, 2023 | Sell | 100 | $26.4 | $2,600 |
Throne Jason | Aug 9, 2023 | Sell | 5,000 | $25.0859 | $130,000 |
Stone Paul A. | Aug 9, 2023 | Sell | 2,500 | $25.0453 | $63,000 |
Throne Jason | Jul 10, 2023 | Sell | 9,485 | $23.0024 | $220,000 |
Throne Jason | Jun 1, 2023 | Sell | 3,553 | $23.0205 | $82,000 |
Throne Jason | May 31, 2023 | Sell | 432 | $23.0035 | $9,900 |
Throne Jason | May 22, 2023 | Sell | 500 | $23 | $12,000 |
What's the latest insider transaction for Ideaya Biosciences?
The most recent insider transaction for Ideaya Biosciences was conducted by WHITE MICHAEL ANTHONY, who sold 27,649 shares on May 29, 2024 at a price of $36.23 per share.
Which insider has sold the most IDYA stock over the last two years?
Hata Yujiro S has sold the most IDYA stock in the last 2 years, with a total value of $18M.
What is the total value of insider transactions for Ideaya Biosciences (IDYA) in the last 2 years?
The total value of insider transactions for Ideaya Biosciences in the last 2 years is negative, amounting to -$20M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Ideaya Biosciences' market confidence?
Over the last 2 years, insider transactions for Ideaya Biosciences have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.